Explore News By Topic

09/04/2018

The Prostate Cancer Foundation Launches PSA Starring Actor Dax Shepard and First-Ever PCF Pushup Challenge as Part of Its ‘Do Blue’ Campaign to Kick-off Prostate Cancer Awareness Month

LOS ANGELES, Calif., September 4, 2018 – This year marks the 25th anniversary of the Prostate Cancer Foundation’s (PCF) efforts of advancing prostate cancer research. In honor of Prostate Cancer Awareness Month this September, PCF is making it the Prostate Cancer ACTION month to create awareness, spark conversations and raise... Read More

09/04/2018

Immunotherapy could offer hope for some men with aggressive prostate cancers

Original Press Release issued by: The Institute of Cancer Research, London Study finds that a subset of men with prostate cancer have ‘mismatch’ DNA repair defects in their tumours These men have very aggressive disease with worse survival on currently available therapies BUT are more likely to benefit from immunotherapy New... Read More

08/28/2018

The Prostate Cancer Foundation Announces Recipients of the 2018 PCF Young Investigator Awards

LOS ANGELES, Calif., August 28, 2018 – The Prostate Cancer Foundation (PCF) announced today that it has granted a total of $6 million to 29 promising early career scientists dedicated to advancing critical research in developing better early detection methods, improving life-saving treatments and finding a cure for prostate cancer.... Read More

08/16/2018

The Prostate Cancer Foundation and the Movember Foundation Announce 2018 Challenge Awards Winners

SANTA MONICA, Calif., August 16, 2018 – The Prostate Cancer Foundation (PCF) and the Movember Foundation today announced four new Movember Foundation-PCF Challenge Award teams at some of the world’s leading academic research institutions will receive a total of $3.5 million to support cross-disciplinary pioneering research toward the goal of finding a cure... Read More

08/01/2018

The Prostate Cancer Foundation Appoints Christine Jones as Chief Operating Officer

SANTA MONICA, Calif., August 1, 2018 – The Prostate Cancer Foundation (PCF) today announced that Christine Jones has been appointed Chief Operating Officer effective immediately reporting to Jonathan W. Simons, MD, President and Chief Executive Officer (CEO). In this role, Ms. Jones will contribute to the strategic growth of the... Read More

07/19/2018

Genomic Landscape of Metastatic Prostate Cancer Unveiled in New Study

A comprehensive genetic analysis of metastatic prostate cancer has, for the first time, revealed a number of major ways in which abnormal alterations of the genome propel this aggressive form of the disease. As reported in the July 19, 2018 issue of Cell, a team led by investigators at UC... Read More

07/17/2018

NIH and Prostate Cancer Foundation launch large study on aggressive prostate cancer in African-American men

The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is called RESPOND, or Research on Prostate Cancer in Men of African Ancestry: Defining the Roles of Genetics, Tumor Markers, and Social Stress. It will... Read More

07/13/2018

BREAKING NEWS: FDA Approves Enzalutamide (Xtandi) for Non-Metastatic Castration-Resistant Prostate Cancer

July 13, 2018 – Today the U.S. Food and Drug Administration (FDA) approved enzalutamide (Xtandi) for the treatment of non-metastatic castration-resistant prostate cancer (non-metastatic CRPC).  Non-metastatic CRPC is a clinical state in which PSA levels begin to rise in patients being treated with androgen deprivation therapy (ADT), but metastases are... Read More

07/11/2018

Deadly Form of Advanced Prostate Cancer is Common, Calls for Distinct Treatment

Original article issued by UCSF News. A new study of prostate cancer in 202 men, whose cancers had spread and were resistant to standard treatment, found that a surprisingly large number of these cancers – about 17 percent – belong to a deadlier subtype of metastatic prostate cancer. Previously, it... Read More

07/10/2018

Tumors Grown in the Lab Provide Insights on Rare Prostate Cancer

Original article issued by Weill Cornell Medicine. Growing miniature tumors from patient’s cells in the laboratory may help scientists personalize treatments for those with a rare form of prostate cancer, according a study by Weill Cornell Medicine and NewYork-Presbyterian scientists. Patients with prostate cancer often receive therapies that reduce levels... Read More